DNMT2/TRDMT1 gene knockout compromises doxorubicin-induced unfolded protein response and sensitizes cancer cells to ER stress-induced apoptosis

Apoptosis. 2023 Feb;28(1-2):166-185. doi: 10.1007/s10495-022-01779-0. Epub 2022 Oct 23.

Abstract

The acidic, hypoxic and nutrient-deprived tumor microenvironment may induce endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) may exert an important cytoprotective role by promoting folding of newly synthesized proteins and cancer cell survival. The lack of DNMT2/TRDMT1 methyltransferase-mediated C38 tRNA methylation compromises translational fidelity that may result in the accumulation of misfolded and aggregated proteins leading to proteotoxic stress-related cell death. In the present study, DNMT2/TRDMT1 gene knockout-mediated effects were investigated during doxorubicin (DOX)-induced ER stress and PERK-, IRE1- and ATF6-orchestrated UPR in four genetically different cellular models of cancer (breast and cervical cancer, osteosarcoma and glioblastoma cells). Upon DOX stimulation, DNMT2/TRDMT1 gene knockout impaired PERK activation and modulated NSUN and 5-methylcytosine RNA-based responses and microRNA profiles. The lack of DNMT2/TRDMT1 gene in DOX-treated four cancer cell lines resulted in decreased levels of four microRNAs, namely, miR-23a-3p, miR-93-5p, miR-125a-5p and miR-191-5p involved in the regulation of several pathways such as ubiquitin-mediated proteolysis, amino acid degradation and translational misregulation in cancer. We conclude that DNMT2/TRDMT1 gene knockout, at least in selected cellular cancer models, affects adaptive responses associated with protein homeostasis networks that during prolonged ER stress may result in increased sensitivity to apoptotic cell death.

Keywords: Cancer cells; DNMT2/TRDMT1; Doxorubicin; ER stress; MicroRNA expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics
  • Doxorubicin / pharmacology
  • Endoplasmic Reticulum Stress / genetics
  • Gene Knockout Techniques
  • Humans
  • Methyltransferases / genetics
  • Methyltransferases / metabolism
  • Methyltransferases / pharmacology
  • MicroRNAs* / genetics
  • Neoplasms*
  • Unfolded Protein Response / genetics
  • eIF-2 Kinase / genetics

Substances

  • Doxorubicin
  • eIF-2 Kinase
  • Methyltransferases
  • MicroRNAs